Pelvic Floor Disorders

01/01/2017 - "Vitamin D levels were associated with a decreased risk of pelvic floor disorders, improved MVHI in women in geriatric age group."
04/01/2019 - "Vitamin D Status in Women with Pelvic Floor Disorders: A Meta-Analysis of Observational Studies."
01/01/2016 - "Future studies may target specific at-risk groups, such as men with BPH or women with pelvic floor disorders for evaluation of the impact of vitamin D supplementation on urinary symptoms."
04/01/2019 - "The current evidence regarding the association between vitamin D status and pelvic floor disorder (PFD) are inconclusive. "
07/01/2017 - "Vitamin D and Pelvic Floor Disorders."

09/01/2011 - "Polypropylene meshes are very effective in the treatment of female pelvic floor disorders. "
11/30/2022 - "Non-absorbable polypropylene (PP) meshes have been widely used in surgical reconstruction of the pelvic floor disorders. "
09/01/2011 - "To assess the complications of polypropylene mesh in the treatment of female pelvic floor disorders. "
09/01/2011 - "Complications of polypropylene mesh for the treatment of female pelvic floor disorders."
03/01/2010 - "Currently, most implants used for reinforcement in surgical treatment of pelvic floor disorders are knitted monofilament polypropylene (PP). "

01/01/2005 - "Management of bladder, prostatic and pelvic floor disorders with botulinum neurotoxin."
03/01/2008 - "Botulinum toxin is an emerging medical therapy with increasing applications in the lower urinary tract and pelvic floor, which has proven to be an effective and safe alternative for the treatment of some refractory pelvic floor disorders."
01/01/2021 - "Treatment for pelvic floor disorders can include medications, botulinum toxin, surgery, physical therapy, and biofeedback. "
12/01/2002 - "Botulinum neurotoxin and other treatments for fissure-in-ano and pelvic floor disorders (Br J Surg 2002; 89: 950-61)."
08/01/2002 - "Botulinum neurotoxin and other treatments for fissure-in-ano and pelvic floor disorders."

01/01/2020 - "Methods: In this review, we examine the mechanism of action, formulations, common clinical use in the genital-urinary tract, and potential clinical use in pelvic floor disorders of botulinum toxin type A. "
01/01/2020 - "Botulinum Toxin A: A Review of Potential Uses in Treatment of Female Urogenital and Pelvic Floor Disorders."
01/01/2011 - "Treatment should include conservative approaches such as Botox injection; in patients with pelvic floor disorders, surgical treatment should be considered."
09/01/2014 - "Health care providers who perform onabotulinumtoxinA injections must have appropriate training and experience in treating women with pelvic floor disorders, operative cystoscopy privileges, and the ability to diagnose and manage any adverse outcomes after onabotulinumtoxinA injections into the bladder. "
06/01/2014 - "Health care providers who perform onabotulinumtoxinA injections must have appropriate training and experience in treating women with pelvic floor disorders, operative cystoscopy privileges, and the ability to diagnose and manage any adverse outcomes after onabotulinumtoxinA injections into the bladder."

05/01/2022 - "Comparison of groups A and P showed higher suspension of point C in group P(-2.6 vs. -4.0, p < 0.05) with no difference in points Ba, Bp, surgical failure rate and de novo pelvic floor disorders. "
01/01/2021 - "In our experience the Laparoscopic-Pelvic Organ Prolapse Suspension seems to be safe and effective as a 1-stage treatment of associated pelvic floor diseases. "
01/01/2021 - "A Minimally Invasive Technique for the 1-Stage Treatment of Complex Pelvic Floor Diseases: Laparoscopic-Pelvic Organ Prolapse Suspension."
01/01/2020 - "Patients' Perceptions on Surgical Care Suspension for Pelvic Floor Disorders During the COVID-19 Pandemic."
01/01/2021 - "At 9 clinical sites in the United States National Institutes of Health and National Institute of Child Health and Human Development Pelvic Floor Disorders Network, 183 postmenopausal women requesting vaginal surgery for symptomatic uterovaginal prolapse were enrolled in a multisite randomized superiority clinical trial, comparing a sacrospinous hysteropexy with graft (hysteropexy) with a vaginal hysterectomy with uterosacral ligament suspension (hysterectomy). "

01/01/2012 - "We present the rationale and design of a randomized-controlled trial, Anticholinergic versus Botulinum Toxin, Comparison Trial for the Treatment of Bothersome Urge Urinary Incontinence: ABC trial, conducted by the NICHD-funded Pelvic Floor Disorders Network. "
01/01/2017 - "The Pelvic Floor Disorders Network study found that anticholinergic medications and onabotulinumtoxinA are efficacious for treating urge urinary incontinence, and Burch colposuspension and retropubic mid urethral polypropylene slings are efficacious for decreasing stress urinary incontinence following pelvic organ prolapse surgery in women with potential stress urinary incontinence. "

12/01/2021 - "An analytical cross-sectional study was conducted in 252 women aged 40-55 without pelvic floor disease with FSFI, pelvic floor muscle strength and the hormone levels. "
01/01/2020 - "To provide an overview of the hormone actions and receptors expressed in the female pelvic floor muscles, relevant for understanding the pelvic floor disorders. "
01/01/2020 - "The literature regarding hormones and pelvic floor disorders was reviewed independently and summarized by the individual members of the sub-committee. "
10/01/2006 - "Role of hormones in the pathophysiology of pelvic floor disorders in women."
01/01/2020 - "Hormone receptor expression is the cornerstone in some hormone-based therapies, which require further detailed studies on the distribution of receptors in particular pelvic floor muscles, as well as their association with muscle effectors, involved in the alterations relevant for understanding pelvic floor disorders."

11/01/2009 - "Mechanical evaluation of synthetic biomaterials used in the correction of pelvic floor disorders--experimental study in rabbits."
11/01/2016 - "Overall, our findings contribute to a greater understanding of the biomaterial properties of the USL/CL complex that is needed for the development of new surgical reconstruction methods and mesh materials for pelvic floor disorders."
08/06/2019 - "Mesenchymal stem cell-based bioengineered constructs: foreign body response, cross-talk with macrophages and impact of biomaterial design strategies for pelvic floor disorders."

01/01/2021 - "The objectives of the study were to compare the imaging findings and patient's perception of barium defecating proctography and dynamic magnetic resonance (MR) proctography in patients with pelvic floor disorders. "
01/01/2021 - "This is a prospective study conducted on patients with pelvic floor disorders who consented to undergo both barium proctography and dynamic MR proctography. "
10/01/2012 - "Barium proctography vs magnetic resonance proctography for pelvic floor disorders: a comparative study."

01/01/2018 - "Eligible cases are participants with FI enrolled in the Controlling Anal Incontinence in women by Performing Anal Exercises with Biofeedback or Loperamide (CAPABLe) trial, a Pelvic Floor Disorders Network trial across eight clinical centers in the United States. "

03/01/2019 - "Conclusion: SNM is a safe and effective therapy for women with various pelvic floor disorders. "
01/01/2018 - "Sacral neuromodulation (SNM) offers promise in the therapy of many pelvic floor disorders. "
11/01/2023 - "Sacral neuromodulation is an established minimally invasive therapy indicated for the treatment of functional pelvic floor disorders. "
03/17/2022 - "Despite the common use of this therapy among pelvic floor physiotherapists, little is known about its effects and effectiveness in pelvic floor disorders. "
01/01/2022 - "Medical charts were abstracted for ICD-9 and ICD-10 codes for pelvic floor disorders, use of endocrine therapy, and CPT codes for pelvic floor surgeries and procedures. "

01/01/2014 - "In addition, biofeedback and sacral nerve stimulation are effective in the treatment of CC caused by pelvic floor disorders. "
01/01/2021 - "Biofeedback for Pelvic Floor Disorders."
12/01/2014 - "Management of pelvic floor disorders: biofeedback and more."
01/01/2023 - "BEST PRACTICE ADVICE 11: Biofeedback therapy may be effective for bloating and distention when a pelvic floor disorder is identified. "
04/23/2019 - "A Practical Guide to Biofeedback Therapy for Pelvic Floor Disorders."

09/01/2012 - "The purposes of this study were: (1) to describe the characteristics of individuals with disorders associated with PFD who were seeking outpatient physical therapy services and (2) to identify the prevalence of specific pelvic-floor disorders in the group. "
01/01/2023 - "Effectiveness of telehealth physical therapy for patients with pelvic floor disorders in a community hospital setting."
01/01/2021 - "Medical records of women attending an IPU for pelvic floor disorders with colocated services, including nutrition, social work, psychiatry, physical therapy, and subspecialty care between October 2017 and December 2018, were included in this retrospective chart review. "
01/01/2021 - "Compliance With Pelvic Floor Physical Therapy in Patients Diagnosed With High-Tone Pelvic Floor Disorders."
09/01/2015 - "Pelvic Floor Physical Therapy as Primary Treatment of Pelvic Floor Disorders With Urinary Urgency and Frequency-Predominant Symptoms."

01/01/2010 - "Putative protective effects of cesarean section on pelvic floor disorders."
04/01/2022 - "While initial discussion of pelvic floor protection often focused very rapidly on the mode of delivery and elective caesarean section as a possible protective intervention, it has become apparent in the last few decades how varied and wide-ranging the options are that can be used to protect against pelvic floor disorders. "
02/01/2021 - "There are ongoing discussions whether cesarean section is the safest mode of childbirth to prevent pelvic floor disorders. "
01/01/2018 - "Models may provide an opportunity before birth to identify women who are at low risk of the development of pelvic floor disorders and may provide institute prevention strategies such as pelvic floor muscle training, weight control, or elective cesarean section for women who are at higher risk. "
10/01/2012 - "The article reviews the current evidence and the role of elective Cesarean section in the prevention of pelvic floor disorders (PFDs). "

01/01/2009 - "The consensus committee recommends larger placebo-controlled and comparative trials to evaluate the efficacy of single and repeat injections, the duration of effect, the optimal dosage and injection technique, the timing for repeat injection, and the short- and long-term safety of the treatment in LUT and pelvic-floor disorders."
09/01/2014 - "Health care providers who perform onabotulinumtoxinA injections must have appropriate training and experience in treating women with pelvic floor disorders, operative cystoscopy privileges, and the ability to diagnose and manage any adverse outcomes after onabotulinumtoxinA injections into the bladder. "
06/01/2014 - "Health care providers who perform onabotulinumtoxinA injections must have appropriate training and experience in treating women with pelvic floor disorders, operative cystoscopy privileges, and the ability to diagnose and manage any adverse outcomes after onabotulinumtoxinA injections into the bladder."